Vicente-Zurdo, D.; Rosales-Conrado, N.; León-González, M.E.; Brunetti, L.; Piemontese, L.; Pereira-Santos, A.R.; Cardoso, S.M.; Madrid, Y.; Chaves, S.; Santos, M.A.
Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease. Biomedicines 2022, 10, 1510.
https://doi.org/10.3390/biomedicines10071510
AMA Style
Vicente-Zurdo D, Rosales-Conrado N, León-González ME, Brunetti L, Piemontese L, Pereira-Santos AR, Cardoso SM, Madrid Y, Chaves S, Santos MA.
Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease. Biomedicines. 2022; 10(7):1510.
https://doi.org/10.3390/biomedicines10071510
Chicago/Turabian Style
Vicente-Zurdo, David, Noelia Rosales-Conrado, M. Eugenia León-González, Leonardo Brunetti, Luca Piemontese, A. Raquel Pereira-Santos, Sandra M. Cardoso, Yolanda Madrid, SÃlvia Chaves, and M. Amélia Santos.
2022. "Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease" Biomedicines 10, no. 7: 1510.
https://doi.org/10.3390/biomedicines10071510
APA Style
Vicente-Zurdo, D., Rosales-Conrado, N., León-González, M. E., Brunetti, L., Piemontese, L., Pereira-Santos, A. R., Cardoso, S. M., Madrid, Y., Chaves, S., & Santos, M. A.
(2022). Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease. Biomedicines, 10(7), 1510.
https://doi.org/10.3390/biomedicines10071510